Biota Holdings Limited of Melbourne, Australia, has announced its Particulars of Loss and Damage in its suit against GlaxoSmithKline (GSK) for failing to support Bio
Restrictions against using brand names have rendered pharmaceutical Direct-to-Consumer Advertising (DTCA) in Europe an informative rather than promotional exercise. DTCA is now broadening its scope, evolving from its narrow publicity orientation to a m
Indian drug manufacturer, Ranbaxy Pharmaceuticals has tentative approval from the U.S. Food and Drug Administration to manufacture and market Glimepiride Tablets, 3 mg and 6 mg.Glimepiride is
FDA has approved a porcine insulin zinc suspension product as the first drug for treating diabetic dogs. Prior to the development of this product, the only treatment veterinarians could use on diabetic dogs was human in
A bill that would limit access to common cold medicines containing pseudoephedrine, an ingredient that can be used to make the highly addictive drug methamphetamine, has been unanimously approved by the Senate judiciary committee.The Combat Met
UK Authorities say they have seized counterfeit packs of the Pfizer cholesterol-lowering drug Lipitor after they entered the legitimate supply chain.According to the
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.The action, which is unprecedented, is aimed
No other medicine is as common, inexpensive, and yet powerful in so many ways as aspirin; yet despite a century of experience with the drug, researchers are still learning important new lessons, while raising new questions, according to seven special a
Medicare drug discount cards are now available for purchase. The US government estimates, the cards could save seniors as much as 25 percent of their prescription drug costs. According to a Harvard study, the cards will save seniors, on average, 17.4 pe
MHRA (Medicines) has recently become aware of a traditional Chinese medicine called Nu Bao. The product patient information leaflet lists human placent
Alvesco is indicated as prophylactic treatment of persistent asthma in adults.
The United Kingdom is serving as the Reference Member State for the European Mutual Recognition Procedure that will be initiated to gain marketing approval for Alvesco in participating countries. This approval of Alvesco in the UK is another major milestone for ALTANA Pharma. Other approvals will follow, so that patients in many countries can benefit from Alvesco.
http://www.altana.de